|
⚲
|
| Keyboard |
| Navimed Capital Advisors LLC
✚
|
|
|---|---|
| CRD # | 169508 |
| SEC # | 801-119184 |
| CIK # | 0001568853, 0001568854, 0001788720 |
| AUM | 904.9 M (2026-04-27) |
| Employees | 14 (86% Investors, 0% Brokers) |
| Fees | |
| Minimum | |
| Phone | 202-817-2850 |
| Address | 1300 Wilson Boulevard Rosslyn, VA 22209-2321 |
| Source | [IAPD] [EDGAR] [Website] [Twitter] [LinkedIn] [Facebook] |
| Total AUM ($M) |
|---|
| Fees and Compensation — Form ADV Part 2A (4/27/2026) [Brochure] |
|---|
Item 5 Fees and Compensation
Advisory Fees
NaviMed Capital or an affiliate receives a management fee, and its affiliated General Partners are
allocated carried interest as compensation for providing investment advisory services to the Funds (as
described below). Differences exist from Fund to Fund, and certain Funds may not charge certain
fees, compensation or expenses that other Funds charge. In addition, the General Partner of each
Fund may, in its sole discretion, waive or reduce an investor’s management fee or carried interest.
Fund investors should refer to each Fund’s Offering Documents for specific information about the
applicable Fund’s fees and expenses.
Management Fee
Each Fund will generally pay an annual “Management Fee” pursuant to the applicable
provisions of such Fund’s Offering Documents. The Management Fee for a Fund is paid in
advance generally by way of a drawdown of capital from investors in the applicable Fund but
may be paid from any other asset owned by the applicable Fund (including amounts received
by the applicable Fund in respect of a portfolio investment and/or reserved by the applicable
Fund). Generally, the Management Fee is not negotiable, provided that NaviMed Capital is
permitted to waive, reduce or otherwise modify the Management Fee for any Limited Partner
in a Fund with the result being that investors in the same Fund may pay different Management
Fees.
Management Offset Fees
From time to time, NaviMed Capital or its affiliates (including the General Partners of one or
more Funds) may receive monitoring fees, transaction fees, upfront fees, and/or breakup fees
from transactions with certain portfolio companies in which one or more Funds are invested.
In these cases, it is generally NaviMed Capital’s policy to allocate each such Fund’s pro-rata
share of such fees to offset the Management Fee payable to NaviMed Capital by the Funds
that participate in a transaction from which the fees were derived. Also, from time to time,
employees or principals of NaviMed Capital serve as directors with respect to portfolio
companies in which one or more Funds invest, and compensation is paid to NaviMed Capital,
its affiliates, or its employees or principals for the provision of the director’s services. In these
instances, it is generally NaviMed Capital’s policy to allocate each such Fund’s pro-rata share
of such compensation received for serving as a director to offset the Management Fee payable
to NaviMed by the Funds that participate in the transaction from which NaviMed Capital
derived the right to the board seat.
As detailed in each applicable Fund’s Offering Documents, any fees paid by a Fund portfolio
company to certain outside experts or professionals (specifically including “Health Policy
Partners” or “Senior Advisors” as such terms are defined by the applicable Fund’s Offering
Documents, as well as terms or titles of similar import) will not be credited against
Management Fees.
Carried Interest Allocation (Performance-Based Fees)
An affiliate of NaviMed Capital receives performance-based compensation from each Limited
Partner (with limited exceptions) in each Fund in connection with the performance by such
affiliate of its duties to the applicable Fund. Generally, such performance or carried interest
allocation is equal to a percentage of distributions otherwise payable to such Limited Partner
after a return to such Limited Partner of its aggregate capital contributions to the applicable
Fund plus an agreed-upon annual return (or performance hurdle). These amounts are paid
from cash otherwise distributable to such Limited Partner, such as receipt by the applicable
Fund of proceeds from a portfolio investment. Generally, the performance allocation is not
negotiable, provided that NaviMed Capital is permitted to waive, reduce or otherwise modify
the performance allocation for any Limited Partner in a Fund with the result being that
investors in the same Fund may pay different performance-based compensation.
Other Fees and Expenses
In addition to the Management Fee and the performance-based compensation discussed above, each
Fund, or in certain cases a Fund’s portfolio company, may be required to reimburse NaviMed Capital
and/or its affiliates for, and/or pay to one or more third parties, all out-of-pocket costs and expenses
attributable to the applicable Fund’s activities, other than ordinary administrative and overhead
expenses of NaviMed Capital incurred in managing the applicable Fund. These additional amounts,
including those identified below, are more fully described in the Offering Documents for each Fund.
As noted earlier, differences may exist with respect to the fees and expenses charged from Fund to
Fund, and certain Funds may not charge for certain fees and expenses. Examples of other fees and
expenses that may be charged to one or more Funds include those set forth below:
Organizational and Offering Expenses
A Fund will generally reimburse NaviMed Capital or an applicable affiliate for all or a stated
portion of the Fund’s organizational expenses incurred in the formation of the Fund and the
offering of the interests. In the event that only a stated portion of organizational expense are
reimbursed by a Fund, organizational expenses in excess of such portion and any placement
agent fees will generally be borne by the Fund but will be subject to a 100% offset against
Management Fees.
Operating Expenses
NaviMed Capital will bear all costs associated with the salaries of its investment and
administrative personnel and its rent, utilities and office space. A Fund will generally pay all
... |
| Account Minimums and Types of Clients — Form ADV Part 2A (4/27/2026) [Brochure] |
|---|
Item 7 Types of Clients As described in Item 4, NaviMed Capital provides investment advisory services to privately offered pooled investment funds including partnerships or other pooled investment vehicles formed under domestic or non-U.S. laws and operated as investment pools that are excluded from the definition of an investment company under the Investment Company Act of 1940, as amended (the “Company Act”). At this time, it is not anticipated that NaviMed will provide advice to advisory clients that are “retail investors” as defined by Rule 204-5(d)(2) under the Investment Advisers Act of 1940, as amended (the “Advisors Act”). Fund investors generally include institutional investors and other sophisticated investors. By virtue of their investment in a Fund, Fund investors are not clients of NaviMed Capital. Each Fund’s Offering Documents impose a minimum contribution for investment, which varies from Fund to Fund. The General Partner of such Fund may waive such minimum commitment requirement in its sole discretion. Each investor in a Fund is required to meet certain suitability qualifications in order to invest, such as being an “accredited investor” within the meaning of Rule 501 under the Securities Act and/or a “qualified purchaser” within the meaning of Section 2(a)(51) of the 1940 Act. In addition, there are prohibitions on withdrawals from a Fund and restrictions on transfers of interests in a Fund. Because of these prohibitions and restrictions, an investment in a Fund is a continuing commitment to invest the amount of capital subscribed for by an investor, is an illiquid investment, and involves a high degree of risk. A subscription for Limited Partner interests in a Fund should be considered only by persons financially able to maintain their investment and who can accept a loss of all of their investment. In order to invest in a Fund that is subject to a performance fee, an investor must be a “qualified client” as defined by Section 205 of the Advisers Act, and Rule 205-3 thereunder. |
| Type | Form D Funds | Date | Sold | AUM |
|---|---|---|---|---|
| PE | Navimed Partners III LP | [2025-03-28] | 450.9 M | |
| Filed 2024-11-12 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Net Assets Decline to Disclose | ||||
| PE | Navimed Partners II LP | [2020-03-30] | 165.9 M | 332.0 M |
| Filed 2020-10-23 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Commission $1,443,750 · Net Assets Decline to Disclose | ||||
| PE | Navimed Partners Executive Fund LP | [2013-10-30] | 4.1 M | 4.7 M |
| Filed 2015-02-18 (D/A) · Exemption 506(b), 3(c), 3(c)(1) · Remaining Indefinite · Duration More than one year · Revenue Decline to Disclose | ||||
| PE | Navimed Partners LP | [2013-10-30] | 107.9 M | 117.3 M |
| Offered $107,881,000 · Filed 2015-07-13 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Duration More than one year · Commission $330,120 · Net Assets Decline to Disclose | ||||
| AUM Breakdown | Accounts | AUM ($M) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 4 | 904.9 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 4 | 904.9 |
| By Discretionary | ||
| Discretionary | 4 | 904.9 |
| Non-Discretionary | 0 | 0.0 |
| Total | 4 | 904.9 |
| By Non-United States Persons | ||
| Non-United States Persons | 0.0 | |
| United States Persons | 904.9 | |
| Total | 4 | 904.9 |
| Form D Directors | Role | # Filings | # Firms | 2011 - 2026 |
|---|---|---|---|---|
| Ryan Ross | Executive Officer | 6 | 3 | |
| Ryan Schwarz | Executive Officer | 31 | 2 | |
| Bijan Salehizadeh | Executive Officer | 26 | 2 | |
| Brian Canann | Executive Officer | 7 | 2 | |
| Kun Seung Lee | Executive Officer | 1 | 1 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| D | [0001568853] | |
| D | [0001568854] | |
| D | [0001788720] |
| Firm Profile (Form ADV) | |
|---|---|
| Serves | Institutional |
| Fund Types | Private Equity |
| Comparable Firms | State | AUM |
|---|---|---|
|
Madryn Asset Management LP
✚
|
NY | 915.0 M |
|
Christopher & Co LLC
✚
|
TX | 913.8 M |
|
RFE Management Corporation
✚
|
CT | 913.3 M |
|
Braemont Capital Management LLC
✚
|
TX | 913.0 M |
|
Estancia Capital Management LLC
✚
|
AZ | 908.0 M |
|
Trimer Capital Management LP
✚
|
CA | 901.5 M |
|
Riata Capital Group LLC
✚
|
TX | 901.1 M |
|
Goldner HAWN LP
✚
|
MN | 898.9 M |
|
Teleo Capital Management LLC
✚
|
ID | 894.1 M |
|
Acorn Growth Companies LC
✚
|
OK | 893.2 M |